Related Experiment Videos
[Visual laser coagulation for benign prostatic hyperplasia. Preliminary experiences]
T Wold1, S J Karlsen, T Bull-Njaa
1Urologisk avdeling, Kirurgisk klinikk, Aker sykehus, Oslo.
Summary
Visual laser coagulation (VLAP) effectively treated benign prostatic hyperplasia, improving urinary flow by 78% with minimal bleeding. Most patients reported satisfaction, though some experienced temporary dysuria.
Area of Science:
- Urology
- Minimally Invasive Surgery
Context:
- Benign prostatic hyperplasia (BPH) causes symptomatic bladder outlet obstruction.
- Visual laser coagulation (VLAP) is a treatment option for BPH.
Purpose:
- To evaluate the efficacy and safety of visual laser coagulation (VLAP) using a neodymium: YAG laser for BPH.
Summary:
- 28 BPH patients underwent outpatient VLAP with a side-firing neodymium: YAG laser at 40 Watts.
- Mean operative time was 34 minutes; 650 J/g prostatic tissue was administered.
- Post-procedure, peak urinary flow increased by 78% (9.0 to 15.4 ml/sec), with high patient satisfaction.
Impact:
- VLAP offers a gentle, effective outpatient treatment for BPH with significant improvement in urinary flow.
- Minor complications included temporary dysuria; two patients required transurethral resection for retention.